1. Овсянников Д.Ю., Бойцова Е.В. Пневмонии у новорожденных детей//Педиатрия. Cons. Medicum. 2021. N 3. P. 214 - 223.

2. Волянюк Е., Сафина А. Врожденная Пневмония У Недоношенных Новорожденных: Особенности Этиологии, Диагностики И Лечения//Практическая Медицина. 2011. Vol. 5, N 53.

3. Бойцова Е.В., Овсянников Д.Ю., Запевалова Е.Ю. [и др.]. Проблемы и дискуссионные вопросы диагностики пневмоний у новорожденных детей//Педиатрия. Журнал им. Г.Н. Сперанского. 2019. Vol. 98, N 2. P. 178 - 185.

4. Черняховский О.Б., Абрамова И.В., Полянчикова О.Л. Внутриутробные инфекции у новорожденных, факторы риска//Российский вестник перинатологии и педиатрии. 2009. Vol. 54, N 1. P. 88.

5. Duke T. Neonatal pneumonia in developing countries//Arch. Dis. Child. Fetal Neonatal Ed. 2005. Vol. 90, N 3. P. 211 - 219.

6. Зубков В.В., Рюмина И.И. Акушерство. Национальное руководство. 2nd-е издание ed./ed. Г.М. Савельевой, Г.Т. Сухих, В.Н. Серова В.Е.Р. Москва: Геотар-Медиа, 2015. 1025 p.

7. Неонатология. Нац. руководство под ред Н.Н. Володина. Москва: ГЭОТАР-Мед, 2007. 848 p.

8. Hooven T.A., Polin R.A. Pneumonia//Semin. Fetal Neonatal Med. 2017. Vol. 22, N 4. P. 206 - 213.

9. Банкалари Э.;под редакцией Р. Полина; перевод с англ.; под ред. Д.Ю. Овсянникова. Легкие новорожденных. Москва: Логосфера, 2015. 672 p.

10. Weston E.J. et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005 - 2008.//Pediatr Infect Dis J. 2011. Vol. 30, N 11. P. 937 - 941.

11. Puopolo K.M. et al. Estimating the probability of neonatal early-onset infection on the basis of maternal risk factors//Pediatrics. 2011. Vol. 128, N 5.

12. Stoll B.J. et al. Early onset neonatal sepsis: The burden of group B streptococcal and E. coli disease continues//Pediatrics. 2011. Vol. 127, N 5. P. 817 - 826.

13. Kuhn P. et al. Incidence and distribution of pathogens in early-onset neonatal sepsis in the era of antenatal antibiotics//Paediatr. Perinat. Epidemiol. 2010. Vol. 24, N 5. P. 479 - 487.

14. Kuzniewicz M.W. et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis//JAMA Pediatr. 2017. Vol. 171, N 4. P. 365 - 371.

15. Sgro M. et al. Population-based study of early-onset neonatal sepsis in Canada//Paediatr. Child Heal. 2019. Vol. 24, N 2. P. E66 - E73.

16. Щеголев А.И., Туманова У.Н., Шувалова М.П., Фролова О.Г. Врожденная пневмония как причина перинатальной смертности в Российской Федерации//Неонатология: новости, мнения, обучение. 2016. Vol. 2, N 12. P. 61 - 66.

17. Cleveland R.H. A radiologic update on medical diseases of the newborn chest//Pediatr. Radiol. 1995. Vol. 25, N 8. P. 631 - 637.

18. Lobo L. The neonatal chest//Eur. J. Radiol. 2006. Vol. 60, N 2. P. 152 - 158.

19. Haney PJ, Bohlman M S.C. Radiographic findings in neonatal pneumonia.//AJR Am J Roentgenol. 1984. Vol. 143, N 1. P. 23 - 26.

20. Swischuk LE. Respiratory system//Imaging of the newborn, infant, and young child. 4th ed. Baltimore: Williams & Wilkins, 1997. P. 43 - 47.

21. Funke A. et al. Frequency, natural course, and outcome of neonatal neutropenia//Pediatrics. 2000. Vol. 106, N 1 I. P. 45 - 51.

22. Ohls R.K. Y.M.C. et al. Hematology, immunology and infection disease: neonatology questions and controversies. Elsiever, 2008. 294 p.

23. Wiedmeier S.E. et al. Platelet reference ranges for neonates, defined using data from over 47000 patients in a multihospital healthcare system//J. Perinatol. 2009. Vol. 29, N 2. P. 130 - 136.

24. Pontrelli G. et al. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: A meta-analysis//BMC Infect. Dis. BMC Infectious Diseases, 2017. Vol. 17, N 1. P. 1 - 12.

25. Hedlund GL, Griscom NT, Cleveland RH K.D. Practical pediatric imaging: diagnostic radiology of infants and children.//Respiratory system. 3rd ed./ed. Kirks DR G.N. Philadelphia: Lippincott-Raven, 1998. P. 715 - 717.

26. Donoqhue V. Radiological Imaging of the Neonatal Chest. 2nd Revise. Springer, 2008. 362 p.

27. Mularoni A. et al. The role of coagulase-negative staphylococci in early onset sepsis in a large European cohort of very low birth weight infants//Pediatr. Infect. Dis. J. 2014. Vol. 33, N 5. P. 121 - 125.

28. Ofman G., Vasco N., Cantey J.B. Risk of Early-Onset Sepsis following Preterm, Prolonged Rupture of Membranes with or without Chorioamnionitis//Am. J. Perinatol. 2016. Vol. 33, N 4. P. 339 - 342.

29. A. et al. Septicemia in the first week of life in a Norwegian national cohort of extremely premature infants//Pediatrics. 2005. Vol. 115, N 3.

30. Soraisham A.S. et al. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants//Am. J. Obstet. Gynecol. 2009. Vol. 200, N 4. P. 372. e1 - 372. e6.

31. Randis T.M., Polin R.A. Early-onset group B Streptococcal sepsis: New recommendations from the Centres for Disease Control and Prevention//Arch. Dis. Child. Fetal Neonatal Ed. 2012. Vol. 97, N 4. P. 291 - 295.

32. Shane A.L., Sanchez P.J., Stoll B.J. Neonatal sepsis//Lancet. 2017. Vol. 390, N 10104. P. 1770 - 1780.

33. Dempsey E. et al. Outcome of neonates less than 30 weeks gestation with histologic chorioamnionitis//Am. J. Perinatol. 2005. Vol. 22, N 3. P. 155 - 159.

34. NG195 N. guidlines. Neonatal infection: antibiotics for prevention and treatment//Neonatal infection: antibiotics for prevention and treatment. 2021. N April.

35. Dior U.P. et al. Very High Intrapartum Fever in Term Pregnancies and Adverse Obstetric and Neonatal Outcomes//Neonatology. 2015. Vol. 109, N 1. P. 62 - 68.

36. Rodrigo F., G.M., Ospina C.G. Morbidity and mortality among very-low-birth-weight infants born to mothers with clinical chorioamnionitis//Pediatr. Neonatol. 2014. Vol. 55, N 5. P. 381 - 386.

37. Rodrigo F.G.M. et al. Outcomes of very-low-birth-weight infants exposed to maternal clinical chorioamnionitis: A multicentre study//Neonatology. 2014. Vol. 106, N 3. P. 229 - 234.

38. Klinger G. et al. Epidemiology and risk factors for early onset sepsis among very-low-birthweight infants//Am. J. Obstet. Gynecol. Mosby, Inc., 2009. Vol. 201, N 1. P. 38. e1 - 38. e6.

39. Singh M., Deorari A.K. Pneumonias in newborn babies//Indian J Pediatr. 1995. Vol. 62, N 3. P. 293 - 306.

40. PA, Johansson PJ S.N. Intrauterine Lung Infection with Chlamydia Trachomatis in a Premature Infant//Acta . 1984. Vol. 73, N 4. P. 569 - 572.

41. Боконбаева С.Д., Нуржанова С.Т. К.А.А. Сравнительный анализ клинического течения врожденных и неонатальных пневмоний//Здоровье матери и ребенка. 2015. Vol. 1. P. 6 - 10.

42. Hedstrom A.B. et al. Performance of the Silverman Andersen Respiratory Severity Score in predicting PCO2 and respiratory support in newborns: A prospective cohort study//J. Perinatol. Springer US, 2018. Vol. 38, N 5. P. 505 - 511.

43. Setty S.G., Batra M., Hedstrom A.B. The Silverman Andersen respiratory severity score can be simplified and still predicts increased neonatal respiratory support//Acta Paediatr. Int. J. Paediatr. 2020. Vol. 109, N 6. P. 1273 - 1275.

44. Sarkar S. et al. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis//J. Perinatol. 2006. Vol. 26, N 1. P. 18 - 22.

45. Polin R.A. et al. Management of Neonates with Suspected or Proven Early-Onset Bacterial Sepsis//Pediatrics. 2012. Vol. 129, N 5. P. 1006 - 1015.

46. H.T. et al. Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin, and interleukin-6 in the diagnosis of neonatal sepsis//Pediatr. Int. 2016. Vol. 58, N 2. P. 119 - 125.

47. Hornik CP, Benjamin DK, Becker KC, Benjamin DK Jr, Li J, Clark RH et al. Use of the complete blood cell count in early-onset neonatal sepsis.//Pediatr Infect Dis J. 2012. Vol. 31, N 8. P. 799 - 802.

48. Murphy K., Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis//Pediatr. Infect. Dis. J. 2012. Vol. 31, N 1. P. 16 - 19.

49. Newman T.B. et al. Combining immature and total neutrophil counts to predict early onset sepsis in term and late preterm newborns: Use of the I/T2//Pediatr. Infect. Dis. J. 2014. Vol. 33, N 8. P. 798 - 802.

50. Makkar M. et al. Performance evaluation of hematologic scoring system in early diagnosis of neonatal sepsis//J. Clin. Neonatol. 2013. Vol. 2, N 1. P. 25.

51. Saboohi E. et al. Immature to total neutrophil ratio as an early indicator of early neonatal sepsis//Pakistan J. Med. Sci. 2019. Vol. 35, N 1. P. 241 - 246.

52. Berardi A. et al. Should we give antibiotics to neonates with mild non-progressive symptoms? A comparison of serial clinical observation and the neonatal sepsis risk calculator//Front. Pediatr. 2022. Vol. 10.

53. Hedegaard S.S., Wisborg K., Hvas A.M. Diagnostic utility of biomarkers for neonatal sepsis - a systematic review//Infect. Dis. (Auckl). 2015. Vol. 47, N 3. P. 117 - 124.

54. Eschborn S., Weitkamp J.H. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis//J. Perinatol. Springer US, 2019. Vol. 39, N 7. P. 893 - 903.

55. Chaudhuri PK, Ghosh A, Sinha V, Singh BK, Singh M, Lugova H, Ahmad R, Sinha S, Haque M K.S. The Role of C-reactive Protein Estimation in Determining the Duration of Antibiotic Therapy in Neonatal Sepsis.//Cureus. 2022. Vol. 14, N 10. P. e30211.

56. Ahmed E., Rehman A., Asghar Ali M. Validation of serum C-reactive protein for the diagnosis and monitoring of antibiotic therapy in neonatal sepsis//Pakistan J. Med. Sci. 2017. Vol. 33, N 6. P. 1434 - 1437.

57. Yochpaz S. et al. C-reactive protein in early-onset neonatal sepsis-a cutoff point for CRP value as a predictor of early-onset neonatal sepsis in term and late preterm infants early after birth?//J. Matern. Neonatal Med. Taylor & Francis, 2020. Vol. 0, N 0. P. 1 - 6.

58. Benitz WE, Han MY, Madan A R.P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection.//Pediatrics. 1998. Vol. 102, N 4. P. E41.

59. Hincu M.A. et al. Relevance of biomarkers currently in use or research for practical diagnosis approach of neonatal early-onset sepsis//Children. 2020. Vol. 7, N 12.

60. Delanghe J.R., Speeckaert M.M. Translational research and biomarkers in neonatal sepsis//Clin. Chim. Acta. Elsevier B.V., 2015. Vol. 451. P. 46 - 64.

61. Hofer N. et al. An update on the use of C-reactive protein in early-Onset neonatal sepsis: Current insights and new tasks//Neonatology. 2012. Vol. 102, N 1. P. 25 - 36.

62. Mjelle AB, Guthe HJT, Reigstad H, AL M.T. Serum concentrations of C-reactive protein in healthy term-born Norwegian infants 48 - 72 hours after birth.//Acta Paediatr. 2019. Vol. 108, N 5. P. 849 - 854.

63. van Maldeghem I, Nusman CM V.D. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis.//BMC Immunol. BMC Immunology, 2019. Vol. 20, N 1. P. 17.

64. Шарафутдинова Д.Р., Балашова Е.Н., Сухова Ю.В., Кесслер Ю.А. [и др.]. Диагностическое значение пресепсина как маркера врожденного инфекционного процесса у новорожденных детей//Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2022. Vol. 21, N 1. P. 56 - 64.

65. Ruan L. et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: A meta-analysis and systematic review//Crit. Care. Critical Care, 2018. Vol. 22, N 1. P. 316.

66. Балашова Е.Н., Шарафутдинова Д.Р., Сухова Ю.В., Кесслер Ю.В., Титова К.Ю., Меньшикова А.А., Киртбая А.Р., Рындин А.Ю., Иванец Т.Ю., Ионов О.В. Д.Д.Н. Диагностическая точность пресепсина, прокальцитонина и C-реактивного белка у новорожденных с ранним неонатальным сепсисом: одноцентровое проспективное исследование//Неонатология: новости, мнения, обучение. 2023. Vol. 11, N 3. P. 10 - 21.

67. Pammi M. et al. Molecular assays for the diagnosis of sepsis in neonates//Cochrane Database Syst. Rev. 2017. Vol. 2017, N 2.

68. Nissen M.D. Congenital and neonatal pneumonia//Paediatr. Respir. Rev. 2007. Vol. 8, N 3. P. 195 - 203.

69. Fitzgerald M.J. et al. Early metabolic effects of sepsis in the preterm infant: Lactic acidosis and increased glucose requirement//J. Pediatr. 1992. Vol. 121, N 6. P. 951 - 955.

70. Di Fiore J.M. et al. Cardiorespiratory events in preterm infants: Interventions and consequences//J. Perinatol. Nature Publishing Group, 2016. Vol. 36, N 4. P. 251 - 258.

71. Davis A.L. et al. American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock//Critical Care Medicine. 2017. Vol. 45, N 6. 1061 - 1093 p.

72. Ломако С.В. Методы ранней диагностики нарушений капиллярного кровотока, позволяющие оптимизировать интенсивную терапию врожденной пневмонии Methods of early diagnosis of capillary blood flow disturbance,//Репродуктивное здоровье. Восточная Европа. 2018. Vol. 8, N 2. P. 219 - 227.

73. Anil N. Importance of measuring lactate levels in children with sepsis//Nurs. Child. Young People. 2017. Vol. 29, N 8. P. 26 - 29.

74. Nadeem M., Clarke A., Dempsey E.M. Day 1 serum lactate values in preterm infants less than 32 weeks gestation//Eur. J. Pediatr. 2010. Vol. 169, N 6. P. 667 - 670.

75. Goryachko A. et al. The Significance of Indicators of Acid-Base State and Biochemical Blood Analysis in Premature Newborns with Different Body Weight and Congenital Pneumonia in the Neonatal Period//Paediatr. East. Eur. 2022. Vol. 10, N 1. P. 96 - 109.

76. Зубков В.В., Байбарина Е.Н., Рюмина И.И. Д.Д.Н. Диагностическая значимость признаков пневмонии у новорожденных детей//Акушерство и гинекология. 2012. Vol. 7. P. 68 - 73.

77. Володин Н.Н., Дегтярев Д.Н., Котик И.Е. И.И.С. Клинико-рентгенологические особенности синдрома дыхательных расстройств и пневмоний у глубоко недоношенных детей//Вопросы гинекологии, акушерства и перинатологии. 2003. Vol. 2, N 5 - 6. P. 16 - 20.

78. Gao Y.Q. et al. Lung ultrasound completely replaced chest X-ray for diagnosing neonatal lung diseases: a 3-year clinical practice report from a neonatal intensive care unit in China//J. Matern. Neonatal Med. Taylor & Francis, 2022. Vol. 35, N 18. P. 3565 - 3572.

79. Xin H., Li J., Hu H.Y. Is Lung Ultrasound Useful for Diagnosing Pneumonia in Children?: A Meta-Analysis and Systematic Review//Ultrasound Q. 2018. Vol. 34, N 1. P. 3 - 10.

80. Corsini I. et al. Lung ultrasound for the differential diagnosis of respiratory distress in neonates//Neonatology. 2019. Vol. 115, N 1. P. 59 - 67.

81. Liu J. et al. Lung ultrasonography for the diagnosis of severe neonatal pneumonia//Chest. The American College of Chest Physicians, 2014. Vol. 146, N 2. P. 383 - 388.

82. Chen S.W. et al. Routine application of lung ultrasonography in the neonatal intensive care unit//Med. (United States). 2017. Vol. 96, N 2.

83. Pereda M.A. et al. Lung ultrasound for the diagnosis of pneumonia in children: A meta-analysis//Pediatrics. 2015. Vol. 135, N 4. P. 714 - 722.

84. Balk D.S. et al. Lung ultrasound compared to chest X-ray for diagnosis of pediatric pneumonia: A meta-analysis//Pediatr. Pulmonol. 2018. Vol. 53, N 8. P. 1130 - 1139.

85. Singh Y. et al. International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC)//Crit Care. Critical Care, 2020. Vol. 24, N 1. P. 1 - 16.

86. Kurepa D. et al. Neonatal lung ultrasound exam guidelines//J. Perinatol. Nature Publishing Group, 2018. Vol. 38, N 1. P. 11 - 22.

87. Горячко А.Н., Сукало А.В. И.Е.В. Прогностическая значимость показателей эхокардиографии, ассоциированных с развитием острой сердечной недостаточности у новорожденных с врожденной пневмонией на первой неделе жизни//Репродуктивное здоровье. Восточная Европа. 2022. Vol. 12, N 2. P. 266 - 280.

88. Gill AB W.A. Echocardiographic assessment of cardiac function in shocked very low birthweight infants [4]//Arch. Dis. Child. 1993. Vol. 61, N 1. P. 17 - 21.

89. Mutlu M. et al. Adrenal hemorrhage in newborns: A retrospective study//World J. Pediatr. 2011. Vol. 7, N 4. P. 355 - 357.

90. Рагимова Н.Д. Особенности ультразвукового исследования органов гепато-билиарной системы и селезенки у новорожденных с внутриутробной инфекцией//Научный альманах. 2015. Vol. 6, N 8. P. 129 - 135.

91. Murase M., Ishida A. Echocardiographic assessment of early circulatory status in preterm infants with suspected intrauterine infection//Arch. Dis. Child. Fetal Neonatal Ed. 2006. Vol. 91, N 2. P. 105 - 110.

92. Bandyopadhyay T. et al. Correlation of functional echocardiography and clinical parameters in term neonates with shock//J. Neonatal. Perinatal. Med. 2020. Vol. 13, N 2. P. 167 - 173.

93. Saini S.S., Kumar P., Kumar R.M. Hemodynamic changes in preterm neonates with septic shock: A prospective observational study//Pediatr. Crit. Care Med. 2014. Vol. 15, N 5. P. 443 - 450.

94. Tomerak R.H. et al. Echocardiogram done early in neonatal sepsis: What does it add?//J. Investig. Med. 2012. Vol. 60, N 4. P. 680 - 684.

95. Basu S. et al. Cerebral blood flow velocity in early-onset neonatal sepsis and its clinical significance//Eur. J. Pediatr. 2012. Vol. 171, N 6. P. 901 - 909.

96. Giannattasio A. et al. Neuroimaging Profiles and Neurodevelopmental Outcome in Infants With Congenital Cytomegalovirus Infection//Pediatr. Infect. Dis. J. 2018. Vol. 37, N 10. P. 1028 - 1033.

97. H. et al. Risk and prognostic factors in perinatal hemorrhagic stroke//Ann. Indian Acad. Neurol. 2021. Vol. 24, N 2. P. 227 - 233.

98. Liakou P. et al. Subcapsular Liver Hematoma-A Life-Threatening Condition in Preterm Neonates-A Case Series and Systematic Review of the Literature//J. Clin. Med. 2022. Vol. 11, N 19. P. 5684.

99. Mon R.A. et al. Diagnostic accuracy of imaging studies in congenital lung malformations//Arch. Dis. Child. Fetal Neonatal Ed. 2019. Vol. 104, N 4. P. F372 - F377.

100. Hermelijn S.M. et al. A clinical guideline for structured assessment of CT-imaging in congenital lung abnormalities//Paediatr. Respir. Rev. The Authors, 2021. Vol. 37. P. 80 - 88.

101. Newman B. et al. Congenital surfactant protein B deficiency - Emphasis on imaging//Pediatr. Radiol. 2001. Vol. 31, N 5. P. 327 - 331.

102. Khalsi F. et al. Congenital surfactant protein B (SP-B) deficiency: a case report//Pan Afr. Med. J. 2023. Vol. 44. P. 158.

103. Badrawi N. et al. Arrhythmia in the neonatal intensive care unit//Pediatr. Cardiol. 2009. Vol. 30, N 3. P. 325 - 330.

104. Lucas J.F. et al. Fatal complete atrioventricular block as a complication of bacterial sepsis in a premature newborn//Pediatr. Cardiol. 2005. Vol. 26, N 5. P. 677 - 679.

105. McMullen S.L. Arrhythmias and Cardiac Bedside Monitoring in the Neonatal Intensive Care Unit//Crit. Care Nurs. Clin. North Am. Elsevier Inc, 2016. Vol. 28, N 3. P. 373 - 386.

106. Schwartz P.J. et al. Guidelines for the interpretation of the neonatal electrocardiogram: A Task Force of the European Society of Cardiology//Eur. Heart J. 2002. Vol. 23, N 17. P. 1329 - 1344.

107. Griffin M.P., Moorman J.R. Toward the early diagnosis of neonatal sepsis and sepsis-like illness using novel heart rate analysis//Pediatrics. 2001. Vol. 107, N 1. P. 97 - 104.

108. H., F., Sertdemir Y. Are vital signs indicative for bacteremia in newborns?//J. Matern. Neonatal Med. 2015. Vol. 28, N 18. P. 2244 - 2249.

109. De Mul A, Parvex P, A, Biran V, Poncet A, Baud O, Saint-Faust M W.-B.A. Urine Output Monitoring for the Diagnosis of Early-Onset Acute Kidney Injury in Very Preterm Infants.//Clin J Am Soc Nephrol. 2022. Vol. 17, N 7. P. 949 - 956.

110. de Boode W.P. Clinical monitoring of systemic hemodynamics in critically ill newborns//Early Hum. Dev. Elsevier Ltd, 2010. Vol. 86, N 3. P. 137 - 141.

111. Hofer N., W., Resch B. Neonates presenting with temperature symptoms: Role in the diagnosis of early onset sepsis//Pediatr. Int. 2012. Vol. 54, N 4. P. 486 - 490.

112. Graves GR R.P. Tachycardia as a sign of early onset neonatal sepsis.//Pediatr Infect Dis. 1984. Vol. 3, N 5. P. 404 - 406.

113. Korvenranta H., Kero P., I. Cardiovascular monitoring in infants with respiratory distress syndrome1//Neonatology. 1983. Vol. 44, N 3. P. 138 - 145.

114. Dempsey E.M. et al. Hypotension in Preterm Infants (HIP) randomised trial//Arch. Dis. Child. Fetal Neonatal Ed. 2021. Vol. 106, N 4. P. F398 - F403.

115. Pellicer A. et al. Early systemic hypotension and vasopressor support in low birth weight infants: Impact on neurodevelopment//Pediatrics. 2009. Vol. 123, N 5. P. 1369 - 1376.

116. Pereira S.S. et al. Blood pressure intervention levels in preterm infants: Pilot randomised trial//Arch. Dis. Child. Fetal Neonatal Ed. 2019. Vol. 104, N 3. P. F298 - F305.

117. Greenough A. et al. Synchronized mechanical ventilation for respiratory support in newborn infants//Cochrane Database Syst. Rev. 2016. Vol. 2016, N 9.

118. McCarthy L.K., O'Donnell C.P.F. Comparison of rectal and axillary temperature measurements in preterm newborns//Arch. Dis. Child. Fetal Neonatal Ed. 2021. Vol. 106, N 5. P. F509 - F513.

119. Gowa M.A. et al. A quasi experimental study to compare thermo-regulator blanket with conventional method (incubator) for temperature regulations in preterm, low birth weight neonates landing at emergency department of a tertiary care paediatric facility//J. Pak. Med. Assoc. 2022. Vol. 72, N 6. P. 1044 - 1047.

120. Korang SK, Safi S, Nava C, Gordon A, Gupta M, Greisen G, Lausten-Thomsen U J.J. Antibiotic regimens for early-onset neonatal sepsis.//Cochrane Database Syst. Rev. 2021. Vol. 2021, N 5. P. CD013837.

121. Moffett S.M., Kitts H.L., Henderson S.J. Medication therapy for early-onset neonatal sepsis//AACN Adv. Crit. Care. 2016. Vol. 27, N 3. P. 253 - 258.

122. Stoll B.J. et al. Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies//JAMA Pediatr. 2020. Vol. 174, N 7. P. 1 - 12.

123. Puopolo KM, Benitz WE Z.T. COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES. Management of Neonates Born at >= 35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.//Pediatrics. 2018. Vol. 142, N 6. P. e20182894.

124. Puopolo KM, Benitz WE Z.T. COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES. Management of Neonates Born at <= 34 6/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.//Pediatrics. 2018. Vol. 142, N 6. P. e20182896.

125. Шухов В.С., Байбарина Е.Н., Рюмина И.И. З.В.. Антимикробная терапия у детей. Практическое руководство. Москва: ГЭОТАР-Медиа, 2016. 320 p.

126. Craig A.M. et al. Listeriosis in Pregnancy: A Review//Obstet. Gynecol. Surv. 2019. Vol. 74, N 6. P. 362 - 368.

127. Flannery DD, Puopolo KM. Neonatal Early-Onset Sepsis.//Neoreviews. 2022. Vol. 23, N 11. P. 756 - 770.

128. Boscarino G. et al. An Overview of Antibiotic Therapy for Early- and Late-Onset Neonatal Sepsis: Current Strategies and Future Prospects//Antibiotics. 2024. Vol. 13, N 3. P. 1 - 12.

129. Sikias P. et al. Early-onset neonatal sepsis in the Paris area: a population-based surveillance study from 2019 to 2021//Arch. Dis. Child. Fetal Neonatal Ed. 2023. Vol. 108, N 2. P. 114 - 120.

130. Fang P. et al. Prevalence of multidrug-resistant pathogens causing neonatal early and late onset sepsis, a retrospective study from the tertiary referral children's hospital//Infect. Drug Resist. 2023. Vol. 16, N June. P. 4213 - 4225.

131. Mendoza-Palomar N. et al. Escherichia coli early-onset sepsis: trends over two decades//Eur. J. Pediatr. European Journal of Pediatrics, 2017. Vol. 176, N 9. P. 1227 - 1234.

132. Ji H. et al. Pathogen Distribution and Antimicrobial Resistance of Early Onset Sepsis in Very Premature Infants: A Real-World Study//Infect. Dis. Ther. Springer Healthcare, 2022. Vol. 11, N 5. P. 1935 - 1947.

133. Weissman S.J. et al. Emergence of antibiotic resistance-associated clones among Escherichia coli recovered from newborns with early-onset sepsis and meningitis in the United States, 2008 - 2009//J. Pediatric Infect. Dis. Soc. 2016. Vol. 5, N 3. P. 269 - 276.

134. Yu Y., Huang Q., Liu A. Analysis of pathogens, drug resistance, sensitive antibiotic treatment and risk factors of early-onset sepsis in very low birth weight infants.//Am. J. Transl. Res. 2021. Vol. 13, N 11. P. 12939 - 12948.

135. Srinivasjois RM, Kohan R, Keil AD S.N. Congenital Mycoplasma pneumoniae pneumonia in a neonate.//Pediatr. Infect. Dis. J. 2008. Vol. 27, N 5. P. 474 - 475.

136. Kimberlin D.W. et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.//J. Pediatr. 2003. Vol. 143, N 1. P. 16 - 25.

137. Kimberlin D.W. et al. Valganciclovir for symptomatic congenital cytomegalovirus disease//N. Engl. J. Med. 2015. Vol. 372, N 10. P. 933 - 943.

138. De Rose D.U. et al. Severe herpes virus 6 interstitial pneumonia in an infant with three variants in genes predisposing to lung disease//J. Med. Virol. 2021. Vol. 93, N 8. P. 5182 - 5187.

139. Langlet C. et al. An uncommon case of disseminated neonatal herpes simplex infection presenting with pneumonia and pleural effusions//Eur. J. Pediatr. 2003. Vol. 162, N 7 - 8. P. 532 - 533.

140. Soll R., E. Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants//Cochrane Database Syst. Rev. 2010. Vol. 1. P. CD001079.

141. Verlato G. et al. Kinetics of surfactant in respiratory diseases of the newborn infant//J. Matern. Neonatal Med. 2004. Vol. 16, N SUPPL. 2. P. 21 - 24.

142. Cogo P.E. et al. Dosing of porcine surfactant: Effect on kinetics and gas exchange in respiratory distress syndrome//Pediatrics. 2009. Vol. 124, N 5.

143. Singh N. et al. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants//Cochrane Database Syst. Rev. 2015. Vol. 2015, N 12.

144. Rojas-Reyes MX, Morley CJ S.R. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants//Neonatology. 2012. Vol. 102, N 3. P. 169 - 171.

145. W. et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): An open-label, randomised, controlled trial//Lancet. Elsevier Ltd, 2011. Vol. 378, N 9803. P. 1627 - 1634.

146. Sweet D.G. et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update//Neonatology. 2019. Vol. 115, N 4. P. 432 - 450.

147. Deshpande S. Surfactant Therapy for Early Onset Pneumonia in Late Preterm and Term Neonates Needing Mechanical Ventilation//J. Clin. Diagnostic Res. 2017. Vol. 11, N 8. P. SC09 - SC12.

148. Polin R.A. et al. Surfactant replacement therapy for preterm and term neonates with respiratory distress//Pediatrics. 2014. Vol. 133, N 1. P. 156 - 163.

149. Vento G, Tana M, Tirone C, Aurilia C, Lio A, Perelli S, Ricci C R.C. Effectiveness of treatment with surfactant in premature infants with respiratory failure and pulmonary infection.//Acta Biomed. 2012. Vol. 83, N suppl 1. P. 33 - 36.

150. Herting E. et al. Surfactant treatment of neonates with respiratory failure and group B streptococcal infection//Pediatrics. 2000. Vol. 106, N 5 I. P. 957 - 964.

151. Rong Z. et al. Bovine surfactant in the treatment of pneumonia-induced-neonatal acute respiratory distress syndrome (NARDS) in neonates beyond 34 weeks of gestation: a multicentre, randomized, assessor-blinded, placebo-controlled trial//Eur. J. Pediatr. European Journal of Pediatrics, 2021. Vol. 180, N 4. P. 1107 - 1115.

152. Bancalari E., Claure N. The evidence for non-invasive ventilation in the preterm infant.//Arch. Dis. Child. Fetal Neonatal Ed. 2013. Vol. 98, N 2. P. 98 - 103.

153. Wilkinson D, Andersen C, O'Donnell CP, De Paoli AG M.B. High flow nasal cannula for respiratory support in preterm infants.//Cochrane Database Syst. Rev. 2016. Vol. 2, N 2. P. CD006405.

154. Hong H. et al. High-flow nasal cannula versus nasal continuous positive airway pressure for respiratory support in preterm infants: a meta-analysis of randomized controlled trials//J. Matern. Neonatal Med. 2021. Vol. 34, N 2. P. 259 - 266.

155. Ramaswamy V.V. et al. Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome: Systematic review and network meta-analysis//Pediatr. Pulmonol. 2020. Vol. 55, N 11. P. 2940 - 2963.

156. Murki S. et al. High-Flow Nasal Cannula versus Nasal Continuous Positive Airway Pressure for Primary Respiratory Support in Preterm Infants with Respiratory Distress: A Randomized Controlled Trial//Neonatology. 2018. Vol. 113, N 3. P. 235 - 241.

157. Dargaville P.A. et al. Continuous positive airway pressure failure in preterm infants: Incidence, predictors and consequences//Neonatology. 2013. Vol. 104, N 1. P. 8 - 14.

158. Moya F.R. et al. Prospective observational study of early respiratory management in preterm neonates less than 35 weeks of gestation//BMC Pediatr. BMC Pediatrics, 2019. Vol. 19, N 1. P. 1 - 10.

159. Hsu J.F. et al. Therapeutic effects and outcomes of rescue high-frequency oscillatory ventilation for premature infants with severe refractory respiratory failure//Sci. Rep. Nature Publishing Group UK, 2021. Vol. 11, N 1. P. 1 - 10.

160. Erickson S.J. et al. Hypocarbia in the ventilated preterm infant and its effect on intraventricular haemorrhage and bronchopulmonary dysplasia//J. Paediatr. Child Health. 2002. Vol. 38, N 6. P. 560 - 562.

161. Cools F. et al. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants//Cochrane Database Syst. Rev. 2015. N 3.

162. Ambalavanan N. et al. PaCO2 in surfactant, positive pressure, and oxygenation randomised trial (SUPPORT)//Arch. Dis. Child. Fetal Neonatal Ed. 2015. Vol. 100, N 2. P. F145 - F149.

163. R. et al. Opioids for newborn infants receiving mechanical ventilation//Cochrane Database Syst. Rev. 2021. N 3.

164. Barrington K.J. Management during the first 72h of age of the periviable infant: An evidence-based review//Semin. Perinatol. 2014. Vol. 38, N 1. P. 17 - 24.

165. Mihatsch W. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium//Clin. Nutr. 2018. Vol. 37, N 6. P. 2360 - 2365.

166. van Goudoever J.B. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Amino acids//Clin. Nutr. 2018. Vol. 37, N 6. P. 2315 - 2323.

167. Joosten K. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Energy//Clin. Nutr. 2018. Vol. 37, N 6. P. 2309 - 2314.

168. Mesotten D. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates//Clin. Nutr. 2018. Vol. 37, N 6. P. 2337 - 2343.

169. Jochum F. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Fluid and electrolytes//Clin. Nutr. 2018. Vol. 37, N 6. P. 2344 - 2353.

170. Lapillonne A. et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids//Clin. Nutr. 2018. Vol. 37, N 6. P. 2324 - 2336.

171. Клинические рекомендации. Нормальная беременность. 2020.

172. Клинические рекомендации. Инфекция мочевых путей при беременности. 2022.

173. Hitchins M. et al. Treatment of persistent methicillin-susceptible Staphylococcus aureus bacteremia and presumed osteomyelitis with oxacillin and ertapenem in a premature neonate//Pharmacotherapy. 2023. Vol. 43, N 1. P. 96 - 99.

174. Akers S.M. et al. Clearance of persistent staphylococcus aureus bacteremia in a preterm neonate with the use of combination cefazolin and ertapenem//J. Pediatr. Pharmacol. Ther. 2020. Vol. 25, N 6. P. 547 - 551.

175. Shabaan A.E. et al. Conventional Versus Prolonged Infusion of Meropenem in Neonates With Gram-negative Late-onset Sepsis: A Randomized Controlled Trial//Pediatr. Infect. Dis. J. 2017. Vol. 36, N 4. P. 358 - 363.

176. Lee S.Y.R., Chow C.B. Safe use of imipenem/cilastatin in a neonatal intensive care unit//Pediatr. Int. 1998. Vol. 40, N 2. P. 186 - 187.

177. Shafiq N, Malhotra S, Gautam V et al. Evaluation of evidence for pharmacokinetics-pharmacodynamics-based dose optimization of antimicrobials for treating Gram-negative infections in neonates.//Indian J Med Res. 2017. Vol. 145, N 3. P. 299 - 316.

178. Reed M.D. et al. Clinical pharmacology of imipenem and cilastatin in premature infants during the first week of life//Antimicrob. Agents Chemother. 1990. Vol. 34, N 6. P. 1172 - 1177.

179. Stuart RL, Turnidge J G.M. Safety of imipenem in neonates.//Pediatr Infect Dis J. 1995. Vol. 14, N 9. P. 803 - 805.

180. Dao K. et al. Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation//J. Antimicrob. Chemother. 2022. Vol. 77, N 2. P. 457 - 465.

181. Freij BJ, McCracken GH Jr, Olsen KD T.N. Pharmacokinetics of imipenem-cilastatin in neonates.//Antimicrob Agents Chemother. 1985. Vol. 27, N 4. P. 431 - 435.

182. PC, Baron S, Challier P, Fontaine JL L.G. Pharmacokinetic and clinical evaluation of imipenem/cilastatin in children and neonates//Scand J Infect Dis Suppl. 1987. Vol. 52. P. 40 - 45.

183. Yoshizawa K, Ikawa K, Ikeda K, Ohge H M.N. Population pharmacokinetic-pharmacodynamic target attainment analysis of imipenem plasma and urine data in neonates and children.//Pediatr Infect Dis J. 2013. Vol. 32, N 11. P. 1208 - 1216.

184. James J., Mulhall A., de Louvois J. Ceftriaxone-clinical experience in the treatment of neonates//J. Infect. 1985. Vol. 11, N 1. P. 25 - 33.

185. Chen D., Ji Y. New insights into Citrobacter freundii sepsis in neonates//Pediatr. Int. 2019. Vol. 61, N 4. P. 375 - 380.

186. Van Reempts PJ, Van Overmeire B, Mahieu LM V.K. Clinical experience with ceftriaxone treatment in the neonate.//Chemotherapy. 1995. Vol. 41, N 4. P. 316 - 322.

187. Silverman W.A. A.D.H. A controlled clinical trial of effects of water mist on obstructive respiratory signs, death rate and necropsy findings among premature infants.//Pediatrics. 1956. Vol. 17, N 1. P. 1 - 10.